110 related articles for article (PubMed ID: 2147802)
1. [Plasmapheresis in the therapy of drug-induced toxicoderma].
Davatdarova MM
Vestn Dermatol Venerol; 1990; (7):32-4. PubMed ID: 2147802
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced skin eruptions: typical treatments for topical problems.
Fisher AA
Geriatrics; 1979 Mar; 34(3):45-51. PubMed ID: 155021
[No Abstract] [Full Text] [Related]
3. [The immunocorrective and detoxifying actions of hemosorption, plasmapheresis and enterosorption in pemphigus].
Grebennikov VA; Beliaevskiĭ AD; Kaminskiĭ MIu; Kuzina ZA; Litvinenko TA
Vestn Dermatol Venerol; 1990; (5):33-8. PubMed ID: 2402939
[TBL] [Abstract][Full Text] [Related]
4. Drug eruptions in geriatric patients.
Fisher AA
Cutis; 1976 Sep; 18(3):402-9. PubMed ID: 138570
[No Abstract] [Full Text] [Related]
5. Intravenous immunoglobulins and plasmapheresis combined treatment in patients with severe toxic epidermal necrolysis: preliminary report.
Lissia M; Figus A; Rubino C
Br J Plast Surg; 2005 Jun; 58(4):504-10. PubMed ID: 15897036
[TBL] [Abstract][Full Text] [Related]
6. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine.
Friedmann PS; Strickland I; Pirmohamed M; Park BK
Arch Dermatol; 1994 May; 130(5):598-604. PubMed ID: 8179341
[TBL] [Abstract][Full Text] [Related]
7. [Plasmapheresis in dermatology].
Potekaev NS; Kurdina MI; Orlov SL; Vorob'ev PA; Gorshkova NN; Barinov VG; Stareev VE
Ter Arkh; 1991; 63(10):133-8. PubMed ID: 1805412
[TBL] [Abstract][Full Text] [Related]
8. Plasmapheresis in severe drug-induced toxic epidermal necrolysis.
Kamanabroo D; Schmitz-Landgraf W; Czarnetzki BM
Arch Dermatol; 1985 Dec; 121(12):1548-9. PubMed ID: 4062337
[TBL] [Abstract][Full Text] [Related]
9. Mucocutaneous eruptions due to antiepileptic drug therapy in children.
Pollack MA; Burk PG; Nathanson G
Ann Neurol; 1979 Mar; 5(3):262-7. PubMed ID: 443758
[TBL] [Abstract][Full Text] [Related]
10. A phenomenon of macrophage aggregation activity in sera of patients with exfoliative erythroderma, erythema multiforme, and erythema nodosum.
Krueger GG; Weston ML; Thorne EG; Mandel MJ; Jacobs RJ
J Invest Dermatol; 1973 May; 60(5):282-5. PubMed ID: 4267209
[No Abstract] [Full Text] [Related]
11. Status of plasmapheresis for the treatment of toxic epidermal necrolysis in Japan.
Yamada H; Takamori K
Ther Apher Dial; 2008 Oct; 12(5):355-9. PubMed ID: 18937717
[TBL] [Abstract][Full Text] [Related]
12. [Clinical manifestations of dermatitis medicamentosa].
Davatdarova MM
Vestn Dermatol Venerol; 1983 Jan; (1):42-6. PubMed ID: 6219509
[No Abstract] [Full Text] [Related]
13. [Drug-induced skin changes].
Ratka P; Włoch J
Przegl Dermatol; 1980; 67(2):199-203. PubMed ID: 6447319
[No Abstract] [Full Text] [Related]
14. [The current concepts of acute toxic-allergic drug reactions and their treatment aspects].
Latysheva TV; Gushchin IS; Poroshina IuA
Ter Arkh; 1991; 63(10):25-37. PubMed ID: 1839582
[No Abstract] [Full Text] [Related]
15. [Plasmapheresis in the combined therapy of Lyell's syndrome].
Khapiĭ KhKh; Kulikova LP; Kil'diushevskiĭ AV
Anesteziol Reanimatol; 1987; (2):61-2. PubMed ID: 3605779
[No Abstract] [Full Text] [Related]
16. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
17. Penicillamine-induced pemphigus foliaceus-like dermatosis. A case with unusual features, successfully treated by plasmapheresis.
Bahmer FA; Bambauer R; Stenger D
Arch Dermatol; 1985 May; 121(5):665-8. PubMed ID: 3158288
[TBL] [Abstract][Full Text] [Related]
18. [Rate of cutaneous drug hypersensitivity].
Adam H
Allerg Immunol (Leipz); 1972; 18(2):73-80. PubMed ID: 4266964
[No Abstract] [Full Text] [Related]
19. Serious and life-threatening drug eruptions.
Manders SM
Am Fam Physician; 1995 Jun; 51(8):1865-72. PubMed ID: 7762478
[TBL] [Abstract][Full Text] [Related]
20. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
